Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
City of Hope Medical Center
Children's Oncology Group
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Stanford University
Augusta University
The University of Texas Health Science Center, Houston
Jazz Pharmaceuticals
University of Florida
Seattle Children's Hospital
Seattle Children's Hospital
Novartis
Valent Technologies, LLC
Emory University
Duke University
City of Hope Medical Center
St. Jude Children's Research Hospital
Bambino Gesù Hospital and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Milton S. Hershey Medical Center
St. Jude Children's Research Hospital
Istari Oncology, Inc.
University of California, San Francisco
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Fudan University
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium
Oncurious NV
Novartis
Jiujiang University Affiliated Hospital
M.D. Anderson Cancer Center
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Lumos Pharma
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Pediatric Brain Tumor Consortium
OHSU Knight Cancer Institute